Articles tagged with Emphysema
The EASE Trial investigates an experimental procedure called airway bypass designed to create pathways in the lung for trapped air to escape, potentially relieving shortness of breath and other symptoms. The study aims to improve lung function and quality of life for emphysema patients.
A randomized double-blind trial of airway bypass treatment is underway to explore a minimally-invasive procedure for millions of emphysema sufferers. The study focuses on reinforcing new pathways in the lung with drug-eluting stents to relieve severe emphysema symptoms.
Researchers at Penn are studying a new airway bypass treatment that creates pathways in the lung for trapped air to escape, relieving emphysema symptoms. The procedure involves placing stents to keep the passageways open and is being tested in an international clinical trial.
Researchers found increased elastin synthesis in moderately diseased lung tissue of COPD patients, suggesting the lungs may be attempting to repair themselves.
A new 'umbrella-like' valve has been shown to be safe and effective for patients with emphysema, improving ventilation and reducing complications. The device, known as the IBV Valve, may provide a noninvasive alternative to lung surgery for patients who are not good candidates.
The latest NETT results confirm that selected severe emphysema patients with upper-lobe emphysema and poor exercise capacity before surgery can benefit from surgery with improved survival rates. Long-term follow-up also shows symptom relief in some patients, but no improvement in overall survival.
Researchers confirm racial biological differences in emphysema distribution and severity between African Americans and Caucasians. The study suggests that the mechanism underlying the disease may vary between races, highlighting the need for targeted antismoking policies and improved treatment options for African American patients.
A study of 149 smokers found that those with extensive facial wrinkles were five times more likely to develop COPD, with triple the risk of severe emphysema. The researchers suggest that facial wrinkling may be a common susceptibility factor for smoking-related lung disease.
Researchers developed a new MRI technique using hyperpolarized helium to detect early signs of emphysema in asymptomatic smokers. The technology shows promise for early disease detection, surgical planning, and monitoring patient response to treatments without radiation exposure.
Researchers at the University of Wisconsin-Madison developed a new approach that tracks helium gas molecules in lungs to detect micro-structural changes in smokers. The technique has shown promise in identifying structural changes in asymptomatic smokers and may help screen for genetic predispositions to conditions like emphysema.
Patients with advanced COPD and rapid lung function decline are 10 times more likely to die than those with normal lung function. The study found that 25% of the population fell into the high-mortality category, with 40 times higher hospitalization rates for those in advanced stages.
Researchers discovered that elastin fragments in mice lungs trigger emphysema. Additionally, a study found that pericyte dysfunction allows tumors to spread by forming leaky blood vessels. Another study identified female mice lacking IBP protein, which makes their T cells resistant to death and contributes to lupus-like disease.
Research finds elastases cause emphysema through generation of pro-inflammatory elastin fragments. Blocking elastin fragment activity prevents emphysema in both mouse models. Elastin fragments are chemotactic, attracting inflammatory cells.
A significant number of emphysema patients experience improved survival, exercise ability, and quality of life after lung-volume reduction surgery. The study confirms earlier findings and suggests the operation should be recommended for many patients with end-stage emphysema.
A study found that 50% tomato juice drink completely prevented smoke-induced emphysema in mice, with lycopene cited as a key contributor. Researchers believe the model can be used to explore pathophysiology and therapeutic intervention for human diseases.
Researchers uncover a new mechanism for post-ischemic arrhythmias, exploring the therapeutic potential of mitochondria-targeting compounds. Leptin signaling is shown to reverse obesity, diabetes, and infertility in mice. FcRn is identified as a promising target for treating autoimmune skin blistering diseases.
Researchers discovered a key gene that protects lungs from damage caused by environmental pollutants and chronic exposure. The study found 50 genes regulated by Nrf2, which work together to defend against cigarette smoke-induced emphysema.
Researchers identified a link between genetic mutations in the ABCA1 gene and lower HDL cholesterol levels in the general population. Approximately 10% of individuals with low HDL levels carry a mutation or nucleotide modification in one of their ABCA1 genes, suggesting that genetic variation plays a role in regulating HDL levels.
Research finds that genetic deletion of the Nrf2 gene makes mice more susceptible to emphysema when exposed to cigarette smoke. This suggests a protective role for Nrf2 against oxidative stress and lung damage.
A K-State researcher found a link between smoking, vitamin A deficiency and emphysema in rats. The study shows that benzopyrene, a common carcinogen in cigarettes, induces vitamin A deficiency, which can lead to increased emphysema scores.
Researchers used CT scans to analyze lung tissue in anorexic patients and found structural changes that differ from those in healthy individuals. The findings suggest early therapy is crucial for patients with anorexia to avoid permanent damage to the lungs.
A specific gene variation, CYP2A6del, may inhibit smokers from quitting and protect against pulmonary emphysema. The study found that this allele was more common in heavy smokers who consumed fewer cigarettes and had a lower risk of developing lung disease.
A national multicenter trial confirms that lung volume reduction surgery (LVRS) significantly improves the quality of life and life expectancy for patients with severe emphysema. The procedure, which involves removing diseased sections of lung tissue, allows patients to resume routine activities without breathing difficulties.
A major government study found that surgery provides significant improvements in pulmonary function, exercise tolerance, and quality of life for selected emphysema patients. The study identified specific criteria, including CT scan patterns and exercise capacity, to determine which patients are best suited for surgical therapy.
The study found that lung surgery improves survival rates and function for some patients with severe emphysema, particularly those with concentrated disease in the upper lobes. However, patients with more diffuse disease and greater exercise capacity are at higher risk of complications.
A landmark cooperative study found that patients with upper lobe emphysema and low exercise capacity benefit more from lung volume reduction surgeries (LVRS), while those without these characteristics experience decreased survival and functional levels. LVRS improved lung function and exercise capacity, but had no long-term benefits.
A study published in the Journal of Thoracic and Cardiovascular Surgery found that lung volume reduction surgery (LVRS) improves breathing capacity by over 50% in select emphysema patients. After five years, patients showed significant improvements in lung function and quality-of-life scores, with an estimated 60% survival rate.
Scientists have improved understanding of TGF-beta's regulation in Marfan syndrome by studying mice with genetic mutations. They found that blocking TGF-beta activity during development may prevent features of the disorder, including emphysema and aortic rupture.
Researchers use helium-3 diffusion MRI to detect emphysema changes in the smallest airways of the lung. The technique reveals enlarged air spaces that allow helium atoms to move freely, enabling the visualization of lung structure at a scale too small for traditional imaging methods.
UCSD researchers identify fibulin-5 as essential for elastic fiber development and organization. Mice without fibulin-5 exhibit severe skin and lung problems, including emphysema and aortic stiffness.
The NETT trial found that advanced emphysema patients with severe lung obstruction or evenly distributed damage should not undergo Lung Volume Reduction Surgery (LVRS). Instead, high-risk patients had a 30-day mortality rate of 16% and only slightly improved functional outcomes six months after surgery.
Researchers have identified scientifically based selection criteria for patients seeking lung volume reduction surgery (LVRS) as a potential treatment for advanced emphysema. High-risk patients with severe lung damage and poor outcomes after surgery are no longer being enrolled in the study, but will continue to receive medical treatment.
A recent study published in the Annals of Internal Medicine found that HIV-positive smokers are up to seven times more likely to develop emphysema. Early emphysema was detected in people with an average age of 35, highlighting the importance of quitting smoking for those living with HIV.
The National Emphysema Treatment Trial (NETT) is enrolling patients with severe emphysema to compare the outcomes of those receiving maximum medical therapy versus those undergoing lung volume reduction surgery. The study aims to assess factors such as exercise ability, longevity, and related issues in both groups.
A recent study found that smoking cannabis regularly may increase the risk of developing emphysema, a disease that damages lung tissue and reduces surface area. The study examined four young men who smoked heavily and found large areas of their lungs had disappeared and been replaced with cysts.
Scientists found that mice lacking the macrophage elastase enzyme showed no signs of emphysema after heavy smoking. This discovery challenges previous theories and offers new hope for emphysema treatment. Researchers are now exploring metalloproteinase inhibitors to prevent the disease.
A major seven-year national study will evaluate the safety and effectiveness of lung volume reduction surgery for people with severe emphysema. Patients selected for the surgery will undergo evaluation and medical therapy at either University of Maryland Medical Center or Johns Hopkins Hospital.
The NHLBI and HCFA have announced a clinical trial to evaluate the safety and effectiveness of lung volume reduction surgery (LVRS) for patients with emphysema. The study aims to determine whether LVRS is a viable treatment option for this population, which currently has limited treatment options.